Yuvezzi

carbachol and brimonidine tartrate · CARBACHOL 27.5 mg/mL; BRIMONIDINE TARTRATE 1 mg/mL · Solution/ Drops · Ophthalmic · Visus Therapeutics, Inc.

NDC 84892-0275-30 · 6 POUCH in 1 CARTON / 5 VIAL, SINGLE-DOSE in 1 POUCH / .16 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application: NDA220142
TE code: —
Approval date: Jan 28, 2026
Patents / exclusivity: 2 patents, 1 exclusivities

Type	Number / code	Expires
exclusivity	NP	Jan 28, 2029
patent	12268662	Nov 10, 2042
patent	8455494	May 24, 2030

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of carbachol and brimonidine tartrate (Solution/ Drops)

Labeler	Strength	First seen	Last seen
Visus Therapeutics, Inc.	CARBACHOL 27.5 mg/mL; BRIMONIDINE TARTRATE 1 mg/mL	Aug 26, 2026	Sep 2, 2026
Visus Therapeutics, Inc.	CARBACHOL 1 mg/mL; BRIMONIDINE TARTRATE 27.5 mg/mL	Jul 22, 2026	Aug 19, 2026
Visus Therapeutics, Inc.	BRIMONIDINE TARTRATE 1 mg/mL; CARBACHOL 27.5 mg/mL	Jul 15, 2026	Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Yuvezzi — NDC 84892-0275-30," retrieved September 3, 2026, https://drugdashboards.com/drug/84892027530.

Free to cite with attribution — see how the data is put together.